BackgroundCheck.run
Search For

Xiao L ZhuBrooklyn, NY

Xiao Zhu Phones & Addresses

Brooklyn, NY   

Philadelphia, PA   

Calera, AL   

Mentions for Xiao L Zhu

Career records & work history

Lawyers & Attorneys

Xiao Zhu Photo 1

Xiao Zhu, New York NY - Lawyer

Address:
Davis Polk & Wardwell LLP
450 Lexington Ave, New York, NY 10017
212-4504731 (Office)
Licenses:
New York - Currently registered 2011
Education:
Columbia Law School

License Records

Xiao Hong Zhu

Address:
Brooklyn, NY
Licenses:
License #: 26NH12119600 - Active
Category: Nursing
Issued Date: Mar 8, 2010
Expiration Date: Nov 30, 2017
Type: Homemaker - HHA

Xiao Hong Zhu

Address:
Brooklyn, NY
Licenses:
License #: 26NH12119600 - Active
Category: Nursing
Issued Date: Mar 8, 2010
Expiration Date: Nov 30, 2017
Type: Homemaker - HHA

Xiao Zhu resumes & CV records

Resumes

Xiao Zhu Photo 31

Xiao Yu Zhu

Xiao Zhu Photo 32

Boss

Industry:
Accounting
Work:

Boss
Xiao Zhu Photo 33

Owner

Industry:
Health, Wellness And Fitness
Work:
Www.chsir.com
Owner
Xiao Zhu Photo 34

Xiao Yong Zhu

Xiao Zhu Photo 35

Xiao Zhu

Xiao Zhu Photo 36

Xiao Fu Zhu

Xiao Zhu Photo 37

Xiao Zhu

Xiao Zhu Photo 38

Xiao Zhu - Middle Village, NY

Work:
Myo Thant, MD, PLLC - Elmhurst, NY Jan 2012 to Jun 2013
Office Manager
Myo Thant, MD, PLLC - Elmhurst, NY Jun 2011 to Dec 2011
Administrative Assistant
Tina Tang Jewelry Co - New York, NY Jan 2011 to Apr 2011
Sales Associate
Education:
Zicklin School of Business, Baruch College, CUNY - New York, NY 2010 to 2013
Bachelors of Business Administration in Finance
Skills:
Proficient use of Microsoft Excel, PowerPoint, Word, and Outlook

Publications & IP owners

Us Patents

Cyclic Dinucleotides As Anticancer Agents

US Patent:
2020027, Aug 27, 2020
Filed:
Aug 30, 2018
Appl. No.:
16/642440
Inventors:
- Princeton NJ, US
Muthoni G. Kamau - Lawrenceville NJ, US
Xiao Zhu - Winchester MA, US
International Classification:
C07H 21/02
C07K 16/28
Abstract:
The present invention is directed to compounds of the formulawherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.

Inhibitors Of Indoleamine 2,3-Dioxygenase And Methods Of Their Use

US Patent:
2020009, Mar 26, 2020
Filed:
May 10, 2018
Appl. No.:
16/612076
Inventors:
- Princeton NJ, US
Emily Charlotte CHERNEY - Newtown PA, US
Liping ZHANG - East Windsor NJ, US
Audris HUANG - New Hope PA, US
Weifang SHAN - Princeton NJ, US
David K. WILLIAMS - Delran NJ, US
Xiao ZHU - Winchester MA, US
Weiwei GUO - Chatham Township NJ, US
International Classification:
C07D 403/12
C07D 213/85
C07D 401/12
C07D 471/04
Abstract:
There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.

Heteroaryl Substituted Aminopyridine Compounds

US Patent:
2018018, Jul 5, 2018
Filed:
Jun 23, 2016
Appl. No.:
15/738362
Inventors:
- Princeton NJ, US
Joseph B. Santella - Springfield PA, US
Venkatram Reddy Paidi - Bangalore, Karnataka, IN
Hong Wu - New Hope PA, US
John V. Duncia - Newtown PA, US
Satheesh Kesavan Nair - Bangalore, Karnataka, IN
John Hynes - Washington Crossing PA, US
Xiao Zhu - Potomac MD, US
International Classification:
C07D 487/04
C07D 471/04
Abstract:
Disclosed are compounds of Formula (I) or salts thereof, wherein HET is a heteroaryl selected from pyrrolo[2,3-b]pyridinyl, pyrrolo[2,3 d]pyrimidinyl, pyrazolo[3,4 b]pyridinyl, pyrazolo[3,4 d]pyrimidinyl, imidazolo[4,5 b]pyridinyl, and imidazolo[4,5 d]pyrimidinyl, wherein said heteroaryl is attached to the pyridinyl group in the compound of Formula (I) by a nitrogen ring atom in said heteroaryl and wherein said heteroaryl is substituted with zero to 2 R; A is pyrazolyl, imidazolyl, triazolyl, isoxazolyl, oxadiazolyl or dihydroisoxazolyl, each substituted with zero or 1 R; and R, R, and Rare define herein. Also disclosed are methods of using such compounds as modulators of IRAK4, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing inflammatory and autoimmune diseases, or in the treatment of cancer.

Isbn (Books And Publications)

Polysaccharides For Drug Delivery And Pharmaceutical Applications

Author:
Xiao Xia Zhu
ISBN #:
0841239606

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.